EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | February 22nd, 2025

Here are the top stories from the last week:

Ride Aid Reveals Generational Gap in Pharmacy Services with Expanded Clinical Care
A new study released by Rite Aid shows how younger generations are more likely to utilize pharmacists for prescribing select medications. Read more »

Study Shows Semaglutide Holds Promise in Reducing Alcohol Cravings
Treatment with semaglutide (Wegovy, Ozempic) yielded superior effects on drinking outcomes compared with existing therapies to reduce alcohol cravings. Read more »

Pharmacists Can Improve Specialty Medication Management in Dermatology
Learn how the University of Louisville Health improved clinical and financial outcomes by embedding a pharmacist in the dermatology clinic. Read more »

Prompting Better Care: Improving Conversations with Question Prompt Lists
Using QPL (Question Prompt Lists) in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise. Read more »

FDA to Review Dupixent for Targeted Treatment of Bullous Pemphigoid
The FDA has accepted Dupixent’s supplemental Biologics License Application for priority review. If approved, it will be the first targeted treatment for bullous pemphigoid in the US. Read more »

Pharmacists Play Vital Role in Stroke Prevention
This article discusses how educating patients about lifestyle modifications is a critical part of preventing cerebrovascular events. Read more »

Single-Dose Malaria Vaccine Demonstrates 90% Efficacy in Early Trials
PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world. Read more »

Walgreens Commits $15 Million to Support the American Heart Association
In an effort to deliver CPR training to communities nationwide, Walgreens has committed $15 million over multiple years in support of the AHA. Read more »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®